Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma

Cytotherapy

Volumn 8, Issue 6, 2006, Pages 580-588

  Zhang, Hong Mei ^a   Zhang, Li Wang ^a   Liu, Wen Chao ^a   Cheng, Jie ^a   Si, Xiao Ming ^a   Ren, Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell fusion; DC; Hepatocellular carcinoma; Immunotherapy; RNA transfection

Indexed keywords

CANCER VACCINE; DENDRITIC CELL VACCINE; RNA;

ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELL FUSION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DRUG SCREENING; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL FUSION; CELL LINE, TUMOR; DENDRITIC CELLS; HLA-A2 ANTIGEN; HUMANS; INTERLEUKIN-1; INTERLEUKIN-12; LIVER NEOPLASMS; NEOPLASMS; PHENOTYPE; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 33845337663     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240600991353     Document Type: Article

References (27)

1. Durr, R and Caselmann, WH. (2000) Carcinogenesis of primary liver malignancies Langenbecks Arch Surg, 385, pp. 154-61.
2. Caselmann, WH and Blum, HE and Fleig, WE and (1999) Guidances of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases Z Gastroenterol, 37, pp. 353-65.
3. Jaffee, EM and Hruban, RH and Biedrzycki, B and (2001) Novel allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation J Clin Oncol, 19, pp. 145-56.
4. Schnurr, M and Galambos, P and Scholz, C and (2001) Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: An in vitro model for the assessment of tumor vaccines Cancer Res, 61, pp. 6445-50.
5. Whiteside, TL and Odoux, C. (2004) Dendritic cell biology and cancer therapy Cancer Immunol Immunother, 53, pp. 240-8.
6. Zitvogel, L and Mayordomo, JI and Tjandrawan, T and (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med, 183, pp. 87-97.
7. Specht, JM and Wang, G and Do, MT and (1997) Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary tumor nodules J Exp Med, 186, pp. 1213-21.
8. Paglia, P and Chiodoni, C and Rodolfo, M and (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo J Exp Med, 183, pp. 317-22.
9. Mayordomo, JI and Zorina, T and Storkus, WJ and (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity Nature Med, 1, pp. 1297-302.
10. Celluzzi, CM and Mayordomo, JI and Storkus, WJ and (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity J Exp Med, 183, pp. 283-7.
11. Thurner, B and Haendle, I and Roder, C and (1999) Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some tumor nodules in advanced stage IV melanoma J Exp Med, 190, pp. 1669-78.
12. Guo, G and Chen, S and Zhang, J and (2005) Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood Vaccine, 23, pp. 5225-30.
13. Kaplan, JM and Yu, Q and Piraino, ST and (1999) Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens J Immunol, 163, pp. 699-707.
14. Nair, SK and Boczkowski, D and Morse, M and (1998) Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA Nat Biotechnol, 16, pp. 364-9.
15. Heiser, A and Coleman, D and Dannull, J and (2002) Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors J Clin Invest, 109, pp. 409-17.
16. Boczkowski, D and Nair, SK and Nam, JH and (2000) Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells Cancer Res, 60, pp. 1028-34.
17. Grunebach, F and Muller, MR and Nencioni, A, B and (2003) Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes Gene Ther, 10, pp. 367-74.
18. Muller, MR and Grunebach, F and Nencioni, A and (2003) Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T-cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes J Immunol, 170, pp. 5892-6.
19. Muller, MR and Grunebach, F and Kayser, K and (2003) Expression of Her-2/ neu on acute lymphoblastic leukemias: Implications for the development of immunotherapeutic approaches Clin Cancer Res, 9, pp. 3448-53.
20. Saeboe-Larssen, S and Fossberg, E and Gaudernack, G. (2002) mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT) J Immunol Methods, 259, pp. 191-203.
21. Ueno, H and Tcherepanova, I and Reygrobellet, O and (2004) Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses J Immunol Methods, 285, pp. 171-80.
22. Anichini, A and Vegetti, C and Mortarini, R. (2004) The paradox of T cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma Cancer Immunol Immunother, 53, pp. 855-64.
23. Kao, JY and Zhang, M and Chen, C-M and (2005) Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer Immunol Lett, 101, pp. 154-9.
24. Nestle, F and Alijagic, S and Gilliet, M and (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med, 4, pp. 328-32.
25. Boon, T and Van der Bruggen, P. (1996) Human tumor antigens recognized by T lymphocytes J Exp Med, 183, pp. 725-9.
26. Ikeda, H and Lethe, B and Lehmann, F and (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity, 6, pp. 199-208.
27. Muller, MR and Tsakou, G and Grunebach, F and (2004) Induction of chronic lymphocytic leukemia (CLL) specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells Blood, 103, pp. 1763-9.